<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04262479710217</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName>Sterile Viscoelastic OVD (Ophthalmic Viscosurgical Device)</deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1010</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-23T19:52:11.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001368</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2493</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001795</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2643</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002150</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0079</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.072Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002280</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.1053</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.034Z</lastUpdated>
  </row>
  <row>
    <udiDi>08699211169495</udiDi>
    <basicUdiDi>B-08699211169495</basicUdiDi>
    <tradeName>CrownVisc</tradeName>
    <deviceName>Sodium Hyaluronat OVD 1.0% 1.0mL</deviceName>
    <manufacturerName>Atakan DEDE - Miray Medikal</manufacturerName>
    <manufacturerSrn>TR-MF-000016028</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MRY-C32</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-16T20:40:51.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>08699211168917</udiDi>
    <basicUdiDi>B-08699211168917</basicUdiDi>
    <tradeName>CrownVisc</tradeName>
    <deviceName>Sodium Hyaluronat OVD 1.8% 1.0mL</deviceName>
    <manufacturerName>Atakan DEDE - Miray Medikal</manufacturerName>
    <manufacturerSrn>TR-MF-000016028</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MRY-C79</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-16T20:40:51.015Z</lastUpdated>
  </row>
  <row>
    <udiDi>08699211168894</udiDi>
    <basicUdiDi>B-08699211168894</basicUdiDi>
    <tradeName>CrownVisc</tradeName>
    <deviceName>Sodium Hyaluronat OVD 1.6% 1.0mL</deviceName>
    <manufacturerName>Atakan DEDE - Miray Medikal</manufacturerName>
    <manufacturerSrn>TR-MF-000016028</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MRY-C78</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-16T20:40:46.991Z</lastUpdated>
  </row>
  <row>
    <udiDi>08699211168863</udiDi>
    <basicUdiDi>B-08699211168863</basicUdiDi>
    <tradeName>CrownVisc</tradeName>
    <deviceName>Sodium Hyaluronat OVD 1.4% 1.0mL</deviceName>
    <manufacturerName>Atakan DEDE - Miray Medikal</manufacturerName>
    <manufacturerSrn>TR-MF-000016028</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MRY-C77</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-16T20:40:46.192Z</lastUpdated>
  </row>
  <row>
    <udiDi>08029408160699</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Ceramol ofta repair</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS312</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-16T08:46:27.428Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002495</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName>Lubricating eye drops with 0.03% sodium hyaluronate</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0085</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-16T05:10:45.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260764172535</udiDi>
    <basicUdiDi>361563Hyaluronate0.2%NFW9</basicUdiDi>
    <tradeName>Augentropfen 0,2% Hyaluron</tradeName>
    <deviceName>HYALURONATE 0.2% NF</deviceName>
    <manufacturerName>UNITHER INDUSTRIES</manufacturerName>
    <manufacturerSrn>FR-MF-000027437</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>4260764172535</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-16T04:54:04.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-USMF0000389680021506A</udiDi>
    <basicUdiDi>B-USMF0000389680021506A</basicUdiDi>
    <tradeName>D-USMF0000389680021506A</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Johnson &amp; Johnson Surgical Vision, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000038968</manufacturerSrn>
    <authorisedRepresentativeName>AMO Ireland</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000013513</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VT585</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-15T10:09:28.018Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000044XT</udiDi>
    <basicUdiDi>B-SEMF000017467000044XT</basicUdiDi>
    <tradeName>D-SEMF000017467000044XT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10271016</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:54.941Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000043XR</udiDi>
    <basicUdiDi>B-SEMF000017467000043XR</basicUdiDi>
    <tradeName>D-SEMF000017467000043XR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10312015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:53.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000042XP</udiDi>
    <basicUdiDi>B-SEMF000017467000042XP</basicUdiDi>
    <tradeName>D-SEMF000017467000042XP</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10311015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:50.943Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000041XM</udiDi>
    <basicUdiDi>B-SEMF000017467000041XM</basicUdiDi>
    <tradeName>D-SEMF000017467000041XM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10310015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:49.342Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000040XK</udiDi>
    <basicUdiDi>B-SEMF000017467000040XK</basicUdiDi>
    <tradeName>D-SEMF000017467000040XK</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10292015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:48.536Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000039Y2</udiDi>
    <basicUdiDi>B-SEMF000017467000039Y2</basicUdiDi>
    <tradeName>D-SEMF000017467000039Y2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10291015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:46.933Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-SEMF000017467000038XY</udiDi>
    <basicUdiDi>B-SEMF000017467000038XY</basicUdiDi>
    <tradeName>D-SEMF000017467000038XY</tradeName>
    <deviceName></deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10290015</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-15T03:14:44.542Z</lastUpdated>
  </row>
</eudamedExport>